No photo of Erica D Warlick
Contact Expert

View Scopus Profile

Erica D Warlick

20072023
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 42 Similar Profiles
Myelodysplastic Syndromes Medicine & Life Sciences
Cell Transplantation Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
Fetal Blood Medicine & Life Sciences
Transplants Medicine & Life Sciences
Transplantation Medicine & Life Sciences
Survival Medicine & Life Sciences
Confidence Intervals Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2008 2023

Predictors of Myelodysplastic Syndrome in Minnesota

Poynter, J., Cioc, A. M., Hirsch, B. A. & Warlick, E. D.

NIH NATIONAL CANCER INSTITUTE (NCI)

3/5/18 → 2/28/23

Project: Research project

Myelodysplastic Syndromes

HM2017-39 Phase III Randomized Study of Crenolanib versus Midostaurin Administered FollowingInduction Chemotherapy and Consolidation Therapy in Newly Diagnosed Subjects with FLT3 MutatedAcute Myeloid Leukemia

Warlick, E. D.

AROG PHARMACEUTICALS, INC

12/1/17 → 11/30/22

Project: Research project

4'-N-benzoylstaurosporine
Consolidation Chemotherapy
Induction Chemotherapy
Myeloid Leukemia
Acute Myeloid Leukemia

A Two-Stage, Open-Label Followed by Placebo-C

Warlick, E. D.

MEI PHARMA, INC

10/1/17 → 2/28/21

Project: Research project

Azacitidine
Myelodysplastic Syndromes
Placebos
SB939 compound

A Multi-Center Randomized Double Blind Placebo-Controlle

Warlick, E. D. & Ustun, C.

National Marrow Donor Program

5/1/17 → 5/30/22

Project: Research project

Placebos
Maintenance
Transplants

A Phase 1/2 study of Vadastuximb Talirine (SGN-CD33A) in

Warlick, E. D.

Seattle Genetics, Inc.

12/30/15 → 12/30/21

Project: Research project

Azacitidine
Myelodysplastic Syndromes

Research Output 2007 2019

Factors predicting early mortality after new diagnosis of myelodysplastic syndrome: A population-based study

Jacobsen, A. M., Poynter, J. N., Richardson, M. R., Nguyen, P. L., Hirsch, B., Cioc, A., Roesler, M. A. & Warlick, E. D., Jul 2019, In : European Journal of Haematology. 103, 1, p. 56-63 8 p.

Research output: Contribution to journal › Article

Myelodysplastic Syndromes
Mortality
Population
Cytogenetics
Chromosome Aberrations

Hematopoietic Cell Transplant–Related Toxicities and Mortality in Frail Recipients

Pamukcuoglu, M., Bhatia, S., Weisdorf, D. J., DeFor, T. E., Ustun, C., Nayar, M., Holtan, S. G., Jurdi, N. E., Thyagarajan, B., Brunstein, C. G., Bachanova, V., Warlick, E. D., Severseike, B., Te, H. S., Lund, T. & Arora, M., Jan 1 2019, (Accepted/In press) In : Biology of Blood and Marrow Transplantation.

Research output: Contribution to journal › Article

Confidence Intervals
Mortality
Nervous System Diseases
Pneumonia
Geriatric Assessment
1 Citation (Scopus)

Predictive value of disease risk comorbidity index for overall survival after allogeneic hematopoietic transplantation

Bejanyan, N., Brunstein, C. G., Cao, Q., Lazaryan, A., Ustun, C., Warlick, E. D., Arora, M., Wagner, J. E. & Weisdorf, D. J., Feb 12 2019, In : Blood Advances. 3, 3, p. 230-236 7 p.

Research output: Contribution to journal › Article

Open Access
Homologous Transplantation
Comorbidity
Survival
Cell Transplantation
Hematologic Neoplasms
1 Citation (Scopus)

Reduced-Intensity Conditioning Followed by Related and Unrelated Allografts for Hematologic Malignancies: Expanded Analysis and Long-Term Follow-Up

Warlick, E. D., DeFor, T. E., Bejanyan, N., Holtan, S., MacMillan, M., Blazar, B. R., Dusenbery, K., Arora, M., Bachanova, V., Cooley, S., Lazaryan, A., McGlave, P., Miller, J. S., Rashidi, A., Slungaard, A., Vercellotti, G., Ustun, C., Brunsein, C. & Weisdorf, D., Jan 2019, In : Biology of Blood and Marrow Transplantation. 25, 1, p. 56-62 7 p.

Research output: Contribution to journal › Article

Open Access
Hematologic Neoplasms
Allografts
Graft vs Host Disease
Cell Transplantation
Transplants
10 Citations (Scopus)

161533 TriKE stimulates NK-cell function to overcome myeloid-derived suppressor cells in MDS

Sarhan, D. A., Brandt, L., Felices, M., Guldevall, K., Lenvik, T. R., Hinderlie, P., Curtsinger, J. M., Warlick, E. D., Spellman, S. R., Blazar, B. R., Weisdorf, D. J., Cooley, S. A., Vallera, D. A., Onfelt, B. & Miller, J. S., Jun 26 2018, In : Blood Advances. 2, 12, p. 1459-1469 11 p.

Research output: Contribution to journal › Article

Open Access
Myelodysplastic Syndromes
Natural Killer Cells
Interleukin-15
Myeloid-Derived Suppressor Cells
Hematopoiesis